James J. Devlin
Comptroller/Controller/Auditor chez CrossAmerica GP LLC
Profil
James J.
Devlin's current job is as a Controller at CrossAmerica GP LLC.
His former jobs include being a Vice President & Controller at Impax Laboratories LLC from 2005 to 2011, and serving as the Chief Accounting Officer & Controller at CrossAmerica Partners LP.
He has an undergraduate degree from LaSalle University and an MBA from St. Joseph's University.
Postes actifs de James J. Devlin
| Sociétés | Poste | Début |
|---|---|---|
CrossAmerica GP LLC
 CrossAmerica GP LLC Wholesale DistributorsDistribution Services CrossAmerica GP LLC provides petroleum products. The company is headquartered in Dover, DE. | Comptroller/Controller/Auditor | 01/07/2012 |
Anciens postes connus de James J. Devlin
| Sociétés | Poste | Fin |
|---|---|---|
| CROSSAMERICA PARTNERS LP | Comptroller/Controller/Auditor | 07/06/2013 |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Comptroller/Controller/Auditor | 01/12/2011 |
Formation de James J. Devlin
| St. Joseph's University | Masters Business Admin |
| LaSalle University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CROSSAMERICA PARTNERS LP | Distribution Services |
| Entreprise privées | 2 |
|---|---|
CrossAmerica GP LLC
CrossAmerica GP LLC Wholesale DistributorsDistribution Services CrossAmerica GP LLC provides petroleum products. The company is headquartered in Dover, DE. | Distribution Services |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Health Technology |
